A protein that can identify potential bladder cancer patients who could benefit from a treatment that makes radiotherapy more effective, has been identified by scientists in Manchester, revealed a study published in the iBritish Journal of Cancer/i (BJC). The team from The University of Manchester, funded by the Medical Research Council, found that patients whose bladder tumour had high levels of a protein, called 'HIF-1 (and) #945;', were more likely to benefit from ...
Read More
You have just read an article categorized health
titled 'Tumor Softening' Treatment Benefiting Bladder Cancer Patients.
Written by:
editor -
Wednesday, July 30, 2014
There are currently no comments for "'Tumor Softening' Treatment Benefiting Bladder Cancer Patients"
Post a Comment